|Articles|September 17, 2020
Resuming Operations After Fungal Contamination Following COVID-19 Shutdown
Author(s)Bioquell
Despite exhausting all disinfection methods after resuming operations this year, this international biologics provider repeatedly failed Environmental Monitoring test standards, delaying $5M in product release. See how Bioquell’s Rapid Bio Decontamination Service provided a fast, effective solution.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
A Scientifically Justified Agitation Stress Model for Early-Stage Biologics
2
Mastering Phase-Appropriate Characterization for Biologics Approval
3
Transforming Clinical Bioanalysis for Manufacturing Scalability
4
From Lab to Patient: The Critical Role of Supply Chain & Distribution in the Life Sciences
5
